Cambridge Technologies is partnering with Merck Animal Health to offer autogenous vaccines for poultry. These customizable products are built from disease-causing isolates currently circulating your region.

In addition to our autogenous products, Cambridge Technologies offers the U.S. poultry industry’s first experimental autogenous vaccine to target Avian Metapneumovirus Type A in combination with Type B in one bottle.

In this partnership, Cambridge Technologies contributes our production expertise and distribution while Merck Animal Health provides field and technical expertise as well as customer networking.

Our full-service Diagnostic Laboratory offers confirmatory testing on a number of diseases and are working to expand our testing menu. Click Here to download a testing request form.